38
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 52 Drug Therapy for Seizure Disorders and Spasticity

Chapter 52 Drug Therapy for Seizure Disorders and Spasticity

Embed Size (px)

DESCRIPTION

Chapter 52 Drug Therapy for Seizure Disorders and Spasticity. Seizure Disorders. Seizure: brief episode of abnormal electrical activity in the brain’s nerve cells May occur as single events May occur in a chronic, recurrent pattern Disorder known as epilepsy - PowerPoint PPT Presentation

Citation preview

Page 1: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Chapter 52

Drug Therapy for Seizure

Disorders and Spasticity

Page 2: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure DisordersSeizure Disorders

• Seizure: brief episode of abnormal electrical activity in the brain’s nerve cells

– May occur as single events

– May occur in a chronic, recurrent pattern

• Disorder known as epilepsy

• Convulsion: tonic–clonic type of seizure characterized by spasmodic contractions of involuntary muscles

Page 3: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

• Is the following statement True or False?

• Seizure and convulsion are different terms for the same disorder.

Page 4: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

• False

• Rationale: A seizure is a brief episode of abnormal electrical activity in the brain’s nerve cells. A convulsion is a tonic–clonic type of seizure characterized by spasmodic contractions of involuntary muscles.

Page 5: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

EpilepsyEpilepsy

• Usually requires long-term therapy

• Characterized by sudden, abnormal, hypersynchronous firing of neurons

• Diagnosed by

– Clinical signs and symptoms of seizure activity

– Presence of abnormal brain wave patterns on EEG

Page 6: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Epilepsy (cont.)Epilepsy (cont.)

• Classifications

– Idiopathic

– Attributable to secondary cause

• Developmental defects

• Metabolic disease, birth injury

• Fever, acquired neurologic disorder

• Alcohol or other drug effects

Page 7: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

• Is the following statement True or False?

• Epilepsy can be classified as either idiopathic or attributable to secondary causes.

Page 8: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

• True

• Rationale: Epilepsy can be classified as either idiopathic or attributable to secondary causes.

Page 9: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure ClassificationsSeizure Classifications

• Partial seizures

– Begin in a specific area of the brain

– Often indicate a localized brain lesion

• Birth injury

• Trauma

• Stroke

• Tumor

Page 10: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)

• Partial seizures (cont.)

– Symptoms range from

• Simple motor and sensory effects

– To

• More complex abnormal movements and bizarre behavior

Page 11: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)

• Partial seizures (cont.)

– Movements are usually

• Automatic

• Repetitive

• Inappropriate to the situation

• Chewing, swallowing

• Aversive movements

Page 12: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)

• Partial seizures (cont.)

– Simple partial seizures

• Consciousness not impaired

– Complex partial seizures

• Level of consciousness is decreased.

Page 13: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

• Is the following statement True or False?

• Partial seizures have no discernible origin in the brain.

Page 14: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

• False

• Rationale: Generalized seizures have no discernible origin in the brain. Partial seizures begin in a specific area of the brain.

Page 15: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)

• Generalized seizures

– Bilateral

– Symmetric

– No discernible point of origin in the brain

– Most common type

• Tonic–clonic

Page 16: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)• Generalized seizures (cont.)

– Absence seizure

• Alteration in consciousness that lasts only a few seconds

– Myoclonic

• Contraction of muscle or group of muscles

– Akinetic

• Absence of movement

Page 17: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)

• Status epilepticus

– Life-threatening emergency

– Characteristics include

• Generalized tonic–clonic convulsions lasting for several minutes

• Generalized tonic–clonic convulsions occurring at close intervals during which consciousness is not regained

Page 18: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)

• Status epilepticus (cont.)

– Characteristics include (cont.)

• Hypotension, hypoxia, and cardiac dysrhythmias

• High risk of permanent brain damage and death

• Unless prompt, appropriate treatment is instituted

Page 19: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Seizure Classifications (cont.)Seizure Classifications (cont.)

• Status epilepticus (cont.)

– Causes

• Abruptly stopping AEDs in diagnosed seizure disorders

• Brain trauma or tumors

• Systemic or CNS infections

• Alcohol withdrawal, drug overdose

Page 20: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Generalized Characteristics of Antiseizure DrugsGeneralized Characteristics of Antiseizure Drugs

• Usually control seizure activity

• Do not cure underlying disorder

• Difficulties

– Trials of different drugs

– Monotherapy versus combination therapy

– Titrating dosage

Page 21: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Generalized Characteristics of Antiseizure Drugs (cont.)Generalized Characteristics of Antiseizure Drugs (cont.)• Difficulties (cont.)

– Lack of seizure control during drug selection and titration

– Social stigma

– Adverse medication effects

• Often leading to poor compliance

– Undesirable drug interactions

Page 22: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

PhenobarbitalPhenobarbital

• Depresses the CNS by inhibiting the conduction of impulses in the ascending reticular activating system, thus depressing the cerebral cortex and cerebellar function

• Used as a sedative and antiepileptic agent in the treatment of generalized tonic–clonic and partial seizures

• Parenteral form is used to control acute seizures.

Page 23: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Adverse Effects Adverse Effects

• CNS depression

• Cognitive impairment with sedation

• Somnolence, agitation, confusion, vertigo, and nightmares

• Stevens-Johnson syndrome

• Black box warning

Page 24: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Benzodiazepines Benzodiazepines

• Used as antidepressants, antiepileptics, or skeletal muscle relaxants

• Used for treatment of severe recurrent convulsive seizures and status epilepticus

• Contraindications include acute narrow-angle glaucoma, shock, coma, acute alcohol intoxication, and pregnancy

Page 25: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

NeurontinNeurontin

• Used in treatment of partial seizures

• It has the ability to inhibit postsynaptic responses and block post-tetanic potentiation.

• Patient teaching

Page 26: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

DilantinDilantin

• Oldest and most widely used antiepileptic

• Stabilizes the neuronal membrane by delaying the influx of sodium ions into the neurons and preventing the excitability caused by excessive stimulation

• Used to control tonic–clonic seizures, psychomotor seizures, and nonepileptic seizures

Page 27: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Adverse Effects Adverse Effects

• Ataxia, drowsiness, lethargy

• Nausea and vomiting

• Gingival hyperplasia

• Increased risk of osteoporosis

• Patient teaching

Page 28: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Monitoring Antiepileptic Drug Therapy Monitoring Antiepileptic Drug Therapy

• Periodic measurement of serum drug levels

– Document blood levels and connections with

• Drug dosages, seizure control, or adverse drug effects

– Assess

• Therapeutic failures

Page 29: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Monitoring Antiepileptic Drug Therapy (cont.)Monitoring Antiepileptic Drug Therapy (cont.)

– Assess (cont.)

• Drug malabsorption

• Patient noncompliance

– Guide dosage adjustments.

– Evaluate possible drug-related adverse effects.

Page 30: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Drug Therapy FailureDrug Therapy Failure

• Causes

– Noncompliance, inadequate drug dosage

– Incorrect diagnosis or medication for seizure type

– Too frequent changes or premature withdrawal

– Drug overdoses, use of alcohol or recreational drugs

– Severe electrolyte imbalance

Page 31: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Use in Special PopulationsUse in Special Populations

• Children

• Older adults

• Patients with renal impairment

• Patients with hepatic impairment

• Patients with critical illness

• Home care

Page 32: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

DefinitionsDefinitions

• Skeletal muscle relaxants are used to decrease muscle spasms or spasticity that occurs within neurologic and musculoskeletal disorders.

– Muscle spasm: sudden, involuntary, painful muscle contraction

• May be clonic or tonic

– Spasticity: increased muscle tone or contraction and stiff, awkward movements

Page 33: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

QuestionQuestion

• Is the following statement True or False?

• Spasticity is a sudden, involuntary, painful muscle contraction.

Page 34: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

AnswerAnswer

• False

• Rationale: Spasticity is increased muscle tone or contraction and stiff, awkward movements. Muscle spasm is a sudden, involuntary, painful muscle contraction.

Page 35: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

General Characteristics of Skeletal Muscle RelaxantsGeneral Characteristics of Skeletal Muscle Relaxants

• Mechanism of action

– General depression of the CNS

• Indications for use

– Primarily as adjuncts to other treatments

• Physical therapy

– Spastic disorders

Page 36: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

General Characteristics of Skeletal Muscle Relaxants (cont.)General Characteristics of Skeletal Muscle Relaxants (cont.)

• Contraindications for use

– Impaired renal or hepatic function

– Respiratory depression

– Patients who must be alert for activities of daily living

Page 37: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Principles of Skeletal Muscle Relaxant TherapyPrinciples of Skeletal Muscle Relaxant Therapy

• Goal: relieve pain, muscle spasm, and muscle spasticity without impairing the ability to perform self-care activities

• Drug selection

– Medication used depends mainly on the disorder being treated.

Page 38: Chapter 52  Drug Therapy for Seizure  Disorders and Spasticity

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Principles of Skeletal Muscle Relaxant Therapy (cont.)Principles of Skeletal Muscle Relaxant Therapy (cont.)

• Use in special populations

– Children

– Older adults

– Impaired renal or hepatic function

– Home care